In vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014 - 2020
- ID: 3641399
- February 2016
- Region: Global
- 149 pages
- Allied Analytics LLP
In vitro fertilization (IVF) is a type of assisted reproductive technology in which the ovum is artificially fertilized in laboratory settings and then implanted into the uterus. IVF is a widely popular treatment, adopted by couples with infertility problems, single mothers, and the LGBT community to procreate.
The world in vitro fertilization devices and consumables market is projected to garner $3,025.2 mllion by 2020, registering a CAGR of 19.7% over the forecast period. The world IVF devices & consumables market is growing significantly owing to rising incidences of infertility, developments in IVF procedures, and growing healthcare expenditures. Furthermore, the rising awareness about infertility and easy availability of IVF treatments, would drive the market growth. Recent technological innovations in the IVF technology, such as embryoscope and capsule IVF, are expected to drive the demand for IVF devices and consumables in future. However, strenuous maintenance issues and inherent high cost associated with the devices limit the growth of the market. The shift in adoption of conventional infertility treatments such as infertility-medication (clomid), to the advanced IVF technologies would boost numerous growth opportunities for the IVF devices market. However, unaffordability of high-end IVF devices is the major challenge faced by local IVF clinics.
The world IVF devices market is segmented into IVF devices, reagent & media, techniques, end users, and geography. The devices considered in this report include sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, IVF cabinet, micromanipulator, and IVF-accessories & disposables among others. The capital equipment set up is the fastest growing segment owing to the increasing number of newly established IVF centers. However, disposables and consumables used during IVF procedures are the highest revenue generating segments.
Based on reagents & media, the market is categorized into, cryopreservation media, semen processing media, ovum processing media and embryo culture media. Cryopreservation media is the highest revenue generating segment owing to its large application during frozen IVF cycles. IVF devices and consumables market by techniques is categorized into, fresh embryo IVF, frozen egg IVF and donor egg IVF. Fresh embryo IVF cycles is the largest revenue generating segment, owing to growing number of couples opting for fresh IVF cycles. The world IVF devices market by end-users is segmented into clinics, hospitals, surgical centres and clinical research institutes. Fertility clinic is the highest revenue generating segment, owing to short patient wait time and higher success rate.
The world IVF devices market is analysed on the basis of geographical regions into North America, Europe, Asia-Pacific, and LAMEA. North America and Europe are the leading revenue generating regions, collectively accounted for about 80% of the market share in 2015. However, the Asia-Pacific region would be the fastest growing region, owing to the high demand for economic IVF services and availability of skilled workforce.Product launch is one of the key strategies adopted by prominent players in the IVF devices and consumables market for the launch of micromanipulators systems, ovum aspiration pumps and IVF accessories among others. These technologies are used in both clinical and research fields. Companies profiled in this report include Vitrolife AB, EMD Serono, Inc., Irvine Scientific, CooperSurgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn, Inc., Oxford Gene Technology, and OvaScience Inc.
KEY MARKET BENEFITS
- An in-depth analysis of current research and clinical developments within world IVF devices market is provided with key market dynamic factors that help in understanding the behavior of market.
- The report provides quantitative analysis of the current market and estimations through 2014-2020, which assists in identifying the prevailing market opportunities.
- A comprehensive analysis of the market scenario in terms of devices, accessories & disposables and reagents & media helps in identifying the prevailing opportunities in the world IVF devices & consumables market.
- An in-depth analysis of current research and developments in the world IVF devices and consumables market provides key market dynamic factors shapes the market dynamics.
- Geographically, the world IVF devices and consumables market is analyzed based on various regions such as North America, Europe, Asia-Pacific, and LAMEA.
- Competitive intelligence (of leading manufacturers and distributors of IVF devices) highlights the business practices followed by leading market players across the geographies.
- SWOT analysis enables to study the internal environment of prominent companies for strategy formulation.
- Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders.
IN VITRO FERTILIZATION DEVICES AND CONSUMABLES MARKET KEY SEGMENTS:
The world IVF devices market is segmented on the basis of instruments, reagents & media, techniques, end users, and geography.
- Sperm Separation System
- Imaging System
- Ovum Aspiration Pump
- Micromanipulator system
- Accessories and Disposables
By Reagents & Media
- Cryopreservation Media
- Semen Processing Media
- Ovum Processing Media
- Embryo Culture Media
- Fresh Embryo IVF
- Frozen Egg IVF
- Donor Egg IVF
By End User
- Surgical Centres
- Clinical Research Institutes
- North America
- United States
- United Kingdom
- Other Europe
- Latin America
- The Middle East
- Africa SHOW LESS READ MORE >
CHAPTER 1 INTRODUCTION
1.1 Report description
1.2 Key market benefits
1.3 Key market segments
1.4 Key audiences
1.5 Research methodology
1.1.1 Secondary research
1.1.2 Primary research
1.1.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 GLOBAL IVF DEVICES & CONSUMABLES MARKET OVERVIEW
3.1 Market definition and scope
3.2 Alternative technologies
3.2.1 Intrauterine Insemination (IUI) Technique
22.214.171.124 Factors assessed for the procedure
126.96.36.199 Benefits of this technique
3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique
188.8.131.52 Difference between GIFT and IVF technique
3.2.4 ZIFT technique
184.108.40.206 Differences between ZIFT and IVF technique
3.3 Replacing IVF procedures by fertility drugs and surgeries
3.3.1 Female infertility treatments
220.127.116.11 Limitations of fertility drugs
3.3.2 Male infertility treatments
3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market
3.5.1 Egg donation
3.5.2 Egg sharing
3.5.3 Sperm donation
3.5.4 Embryo donation/adoption
3.5.5 Donation for research
3.6.1 Legal issues
3.7 IVF trends in same sex couples
3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization
3.8 Advanced IVF technologies
3.8.1 Capsule IVF
3.8.2 Three parent IVF
18.104.22.168 Ethical concerns
3.8.3 Mini IVF
3.9 Fertility treatment and gender selection
3.9.1 Methods of sex selection
22.214.171.124 Gradient method
126.96.36.199 Flow cytometry technique
188.8.131.52 Pre-implantation genetic diagnosis (PGD)
184.108.40.206 Ethical and legal issues
3.10 Metabolomics in embryo screening methods
3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Key Findings
3.13.1 Top factors impacting
3.13.2 Top investment pockets
3.13.3 Top winning strategies
3.14 Porters five forces analysis
3.14.1 High competition and large number reduces the power of suppliers
3.14.2 Scattered nature and large count of end users moderates the buyer power
3.14.3 High capital cost lowers the threat of new entrants
3.14.4 Industry rivalry is intense due to presence of few dominant competitors
3.14.5 Lack of efficient substitutes lowers the threat from substitutes
3.15 Value chain analysis
3.16 Patent analysis
3.16.1 Patent analysis by type of patents
3.16.2 Patents Analysis by geography
3.17 Regulatory issues and legislations
3.18 Insurance reimbursement scenario
3.19 Clinical trials
3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures
3.20.1 Delayed pregnancies in women
3.20.2 Rise in global infertility rates
3.20.3 Advancement in technology
3.20.4 Rise in gamete donations
3.20.5 Rise in disposable income
3.20.6 Increase in success rates
3.21.1 Cost constraints
3.21.2 Ethical and legal issues
3.21.3 Multiple pregnancies
3.21.4 Low awareness level
3.22.1 Fertility tourism
3.22.2 Growing number of fertility clinics
3.22.3 Rise in same sex marriages
CHAPTER 4 GLOBAL IVF DEVICES & CONSUMABLES MARKET BY INSTRUMENTS
4.1 Global IVF market by instrument, 2014-2020, ($million)
220.127.116.11 Global IVF incubators market by geography
18.104.22.168 Global IVF cryosystem market by geography
4.1.3 Imaging system
22.214.171.124 Global IVF Imaging system market by geography
4.1.4 Cabinet (work station)
126.96.36.199 Global IVF cabinets market by geography
4.1.5 Ovum aspiration pump
188.8.131.52 Global IVF ovum aspiration pump market by geography
4.1.6 Sperm separation system
184.108.40.206 Global IVF Sperm separation system market by geography
4.1.7 Micro manipulator system
220.127.116.11 Global IVF Micromanipulator market by geography
18.104.22.168 Global IVF other instruments market by geography
4.2 Accessories and disposables
4.2.1 Semen analysis chamber
4.2.2 Plastic ware
4.2.3 Oocyte retrieval needles
4.2.4 Miscellaneous disposables
4.2.5 Global IVF accessories and disposables market by geography
CHAPTER 5 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY REAGENTS & MEDIA
5.1 Global IVF market by reagents & media, 2014-2020, ($million)
5.2 Cryopreservation media
5.2.1 Embryo cryopreservation media
5.2.2 Sperm cryopreservation media
5.2.3 Oocyte cryopreservation media
5.2.4 Global IVF cryopreservation media market by geography
5.3 Semen processing media
5.3.1 Global IVF semen processing media market by geography
5.4 Ovum processing media
5.4.1 Global IVF ovum processing media market by geography
5.5 Embryo culture media
5.5.1 Global IVF embryo culture media market by geography
CHAPTER 6 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY TECHNIQUE
6.1 Global IVF market, by technique, 2014-2020 ($Million)
6.2 Fresh embryo transfer technique
22.214.171.124 trends of Delayed pregnancies
126.96.36.199 Growing rates of infertility
188.8.131.52 Cost involved in the treatment
184.108.40.206 reimbursements issues with fresh embryo ivf cycles
6.2.3 Global fresh embryo IVF cycle market, by geography
6.3 Frozen Embryo Transfer technique (FER)
6.3.1 Reasons to use this technique
6.3.2 Advantages of Frozen egg IVF technique
6.3.3 Disadvantages of frozen egg IVF technique
6.3.4 Global frozen egg IVF cycle market, by geography
6.4 Donor Egg IVF technique
6.4.1 Benefits of donor egg IVF technique
6.4.2 Risks associated with donor egg IVF cycle technique
6.4.3 Global donor egg IVF cycle market by geography
CHAPTER 7 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY END USERS
7.1 Global IVF market by end user, 2014-2020 ($Million)
7.2.1 Global IVF hospitals market by geography
7.3 Surgical centers
7.4 Clinical research institutes
7.4.1 Global IVF clinical research institutes market by geography
7.5.1 Global IVF Clinics market by geography
CHAPTER 8 GLOBAL IVF DEVICES & CONSUMABLES MARKET, BY GEOGRAPHY
8.1 North America
8.1.1 North America IVF devices and consumables market, by country
220.127.116.11 United States IVF devices and consumables market
18.104.22.168 Canada IVF devices and consumables market
22.214.171.124 Mexico IVF devices and consumables market
8.2.1 Europe IVF devices and consumables market, by component
126.96.36.199 Germany IVF devices and consumables market
188.8.131.52 France IVF devices and consumables market
184.108.40.206 United Kingdom IVF devices and consumables market
220.127.116.11 Other Europe IVF devices and consumables market
8.3.1 Asia-Pacific IVF devices & consumables market, by component
18.104.22.168 India IVF devices & consumables market
22.214.171.124 China IVF devices & consumables market
126.96.36.199 Japan IVF devices & consumables market
188.8.131.52 Australia IVF devices & consumables market
184.108.40.206 other Asia-pacific IVF devices & consumables market
8.4.1 LAMEA IVF devices & consumables market, by component
220.127.116.11 Latin America IVF devices & consumables market
18.104.22.168 Middle East IVF devices & consumables market
22.214.171.124 Africa IVF devices & consumables market
CHAPTER 9 COMPANY PROFILE
9.1 Vitrolife AB
9.1.1 Company overview
9.1.2 Business performance
9.1.3 Strategic moves and developments
9.1.4 SWOT analysis of Vitrolife AB
9.2 EMD Serono, Inc.
9.2.1 Company overview
9.2.2 Business performance
9.2.3 Strategic moves and developments
9.2.4 SWOT analysis of EMD Serono, Inc.
9.3 Irvine Scientific
9.3.1 Company overview
9.3.2 Business performance
9.3.3 Strategic moves and developments
9.3.4 SWOT analysis of Irvine scientific
9.4 CooperSurgical, Inc. (Origio)
9.4.1 Company overview
9.4.2 Business performance
9.4.3 Strategic moves and developments
9.4.4 SWOT analysis of CooperSurgical, Inc.
9.5 Cook Medical, Inc.
9.5.1 Company overview
9.5.2 Strategic moves and developments
9.5.3 SWOT analysis of Cook medical, Inc.
9.6 Thermo Fisher Scientific Inc.
9.6.1 Company overview:
9.6.2 Business performance
9.6.3 Strategic moves and developments
9.6.4 SWOT analysis of Thermo Fisher Scientific, Inc.
9.7 Genea Biomedx
9.7.1 Company overview
9.7.2 Strategic moves and developments
9.7.3 SWOT Analysis of Genea Biomedx
9.8 Auxogyn, Inc.
9.8.1 Company overview
9.8.2 Strategic moves and developments
126.96.36.199 Primary strategies
188.8.131.52 Other strategies
9.8.3 SWOT Analysis of Auxogyn, Inc.
9.9 Oxford Gene Technology
9.9.1 Company overview
9.9.2 Strategic moves and developments
9.9.3 SWOT analysis of Oxford Gene Technology
9.10 Ovascience Inc.
9.10.1 Company overview
9.10.2 Business performance
9.10.3 Strategic moves and developments
9.10.4 SWOT analysis of OvaScience, Inc.
List of Tables
Table 1 World Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 2 World Home Decor Market Revenue By Geography, 2014-2020 ($Million)
Table 3 World Furniture Market Revenue By Type, 2014-2020 ($Million)
Table 4 World Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 5 World Kitchen Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 6 World Living & Bedroom Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 7 World Bathroom Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 8 World Outdoor Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 9 World Lighting Furniture Market Revenue By Geography, 2014-2020 ($Million)
Table 10 World Home Textile Market Revenue By Type, 2014-2020 ($Million)
Table 11 World Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 12 World Rug Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 13 World Bath Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 14 World Bed Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 15 World Kitchen & Dining Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 16 World Living Room Home Textile Market Revenue By Geography, 2014-2020 ($Million)
Table 17 World Floor Covering Market Revenue By Type, 2014-2020 ($Million)
Table 18 World Floor Covering Market By Geography, 2014-2020 ($Million)
Table 19 World Tile Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 20 World Wood & Laminate Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 21 World Vinyl & Rubber Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 22 World Carpet & Rugs Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 23 World Other Floor Covering Market Revenue By Geography, 2014-2020 ($Million)
Table 24 North America Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 25 Europe Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 26 Asia-Pacific Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 27 LAMEA Home Decor Market Revenue By Product, 2014-2020 ($Million)
Table 28 Snapshot Of Inter Ikea Group
Table 29 Snapshot Of Forbo International Sa
Table 30 Snapshot Of Armstrong World Industries, Inc.
Table 31 Snapshot Of Mannington Mills Inc.
Table 32 Snapshot Of Mohawk Industries Inc.
Table 33 Snapshot Of Shaw Industries
Table 34 Snapshot Of Herman Miller Inc.
Table 35 Snapshot Of Ashley Furniture Industries, Inc.
Table 36 Snapshot Of Kimball International
Table 37 Snapshot Of Duresta Upholstery Ltd.
List of Figures
Fig. 1 IVF Devices And Consumables Market Definition
Fig. 2 Asia-Pacific Adoption Rate By Type Of Surrogacy
Fig. 3 Top Impacting Factors (2014-2020)
Fig. 4 Top Investment Pockets Of Global IVF Devices And Consumables Market (2014-2020)
Fig. 5 Top Winning Strategies In Global IVF Devices And Consumables Market 20122015
Fig. 6 Top Winning Strategies In Global IVF Devices And Consumables Market, 2012-2015
Fig. 7 Porters Five Forces Analysis
Fig. 8 Value Chain Analysis Of Global IVF Market
Fig. 9 Patent Analysis By Type Of Patents (2011-2015)
Fig. 10 Patent Analysis By Geography (2011-2015)
Fig. 11 Effect Of Age On Fertility
Fig. 12 Comparison Of The Media Used In Embryo Culture
Fig. 13 Success Rate Of IVF Techniques Performed By Age, 2013, U.S.
Fig. 14 Pregnancy Rate, Per Frozen Embryo Transfer, 2013 (U.S.)
Fig. 15 Vitrolife Ab, Sales Per Region, 2014
Fig. 16 Vitrolife Ab, Revenues ($Million), 2012-2014
Fig. 17 Swot Analysis Of Vitrolife Ab
Fig. 18 Emd Serono Sales By Region, 2012
Fig. 19 Swot Analysis Of Emd Serono, Inc.
Fig. 20 Swot Analysis Of Irvine Scientific
Fig. 21 Swot Analysis Of Cooper Surgical, Inc.
Fig. 22 Swot Analysis Of Cook Medical, Inc.
Fig. 23 Thermo Fisher Scientific, Inc. Financial Revenues By Business Units (2013)
Fig. 24 Financial Revenues By Geographic Areas (2013)
Fig. 25 Swot Analysis Of Thermo Fisher Scientific, Inc.
Fig. 26 Swot Analysis Of Genea Biomedx
Fig. 27 Swot Analysis Of Auxogyn, Inc.
Fig. 28 Swot Analysis Of Oxford Gene Technology
Fig. 29 Swot Analysis Of Ovascience, Inc.
According to a new report titled, “World In Vitro Fertilization Devices and Consumables Market - Opportunities and Forecasts, 2014–2020", global sales of IVF devices and consumables is projected to reach $3 billion by 2020. The IVF disposables and reagent segments collectively accounts for more than three fourth of the market revenue, owing to an increasing number of overall IVF cycles. globally. Europe is the highest revenue generating segment and accounts for around two fifth of the world IVF market share.
In Vitro fertilization (IVF) is a type of assisted reproductive technology, adopted by couples, single mothers, and the LGBT community to deal with infertility conditions. Rising global infertility rates, increasing IVF success rates, and growing per capita healthcare expenditures are boosting the growth of the IVF devices & consumables market. Furthermore, delayed pregnancies and recent innovations in the IVF technology, such as embryoscope and capsule IVF would supplement the market growth. Active government initiatives for LGBT marriages, development of cost-effective IVF procedures and the popularity of fertility tourism is expected to further boost the market growth. However, legal and ethical issues related to IVF treatments, lack of awareness among patients in developing economies, and high costs of IVF devices would limit the market growth.
Capital equipment, such as micromanipulator, IVF cabinets, incubators, and imaging system used in the IVF procedures accounts for the highest share i.e. around 75% in the IVF devices segment. This is attributed to the long shelf-life and high cost related to capital equipment during the IVF procedures. Geographically, Europe would continue to maintain its lead position, owing to the heavy investments made by companies, high affordability, and increasing demand for IVF procedures. This region is expected to grow at a CAGR of 18.2% due to the sophisticated and cost-effective hospitality services and availability of skilled work forces. However, Asia-Pacific is the most lucrative market owing to the rising infertility cases, economic pricing, favorable government regulations, and reimbursements.
Key findings of the study:
- The IVF devices market is expected to grow at a CAGR of 28.4% during the forecast period.
- In the reagents & media segment, cryopreservation media held about 35% of the revenue share in 2015.
- Disposables and consumables used during IVF would remain the highest revenue generating segment throughout the analysis period.
- Fresh IVF cycle was the largest revenue generating IVF technique in 2015 and would continue to maintain this trend untill 2020.
- The IVF clinics segment is expected to be the leading end-users segment through 2020.
Key players operating in this market are largely focusing on product launch as key developmental strategies. Companies are striving to occupy the highest market share through novel product launches such as fully automated vitrification instruments and time-lapse technology.
Leading players profiled in this report are Vitrolife AB, EMD Serono, Inc., Irvine Scientific, CooperSurgical, Inc., Cook Medical, Inc., Thermo Fisher Scientific, Inc., Genea Biomedx, Auxogyn Inc., Oxford Gene Technology, and OvaScience Inc.